-
Japan protests Putin's first visit to disputed islands
-
Hasan takes 6-55 as Bangladesh bundle out Australia for 198
-
Kiss wants fit-again Wallabies playmaker Gordon to 'open up' Japan
-
Swiatek sinks Svitolina to set up Rybakina title clash in Toronto
-
British eccentrics push humble garden shed to new heights
-
Australia's Pallister shines, mixed relay record falls as Pan Pacs open
-
Zambia votes with president's economic record on the line
-
Hasan puts Bangladesh in charge as Australia struggle to 183-8
-
Germany's dry rivers spark battle on engineering vs restoration
-
Putin visits Kuril islands claimed by Japan
-
Senators demand inquiry into conditions aboard USS Abraham Lincoln
-
Swiatek downs Svitolina to reach first WTA final of 2026
-
All Blacks' Proctor out of South Africa series, Mo'unga called up
-
Jones says Japan 'watching videos of geese' for Australia clash
-
Bangladesh quick Hasan reduces Australia to 74-4 at lunch
-
Bloodied but unbowed, defending champ Shelton reaches Montreal final
-
Seoul tech leads Asian stock gains as traders cheer US inflation
-
Wallabies make eight changes for return Japan Test
-
Farage and Count Binface go head-to-head in snap UK poll
-
Messi returns after father's death but Miami knocked out of Leagues Cup
-
Afghan students divided over smartphone ban at universities
-
Outflanked by AI, stars fade for South Korea's blind fortune-tellers
-
Japan go back to school for second Australia Test
-
Venezuela govt, opposition wrap up round of post-Maduro talks
-
Matthew McConaughey on his sweet return to the big screen
-
Five things to know about Zambia as it goes to the polls
-
President's economic record on the line as Zambia votes
-
Nakashima holds off Jodar to book first ATP Masters final in Montreal
-
Battery X Metals Appoints Lithium-Ion Battery and Electric Vehicle Entrepreneur William Fan as President to Advance Development of Its Patent-Pending Lithium-Ion Battery Rebalancing Technology Platform and Corporate Growth Initiatives
-
Battery X Metals Maintains Y Lithium Project Claims in Good Standing and Evaluates Phase I Exploration Program
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 13
-
Battery X Metals Announces Closing of Second Tranche of Private Placement to Advance Corporate Growth Initiatives
-
3 Home Repairs You Can't Afford to Put Off
-
Grieving Messi available for Miami in Leagues Cup clash
-
Trump 'low-key' bets on economic pressure against Iran
-
Colombia enters 'final phase' of quake search as toll hits 265
-
Pitch invaders take selfies with Fernandes during Man Utd friendly
-
Father-figure Christie helps guide Kounta to European silver
-
No-stress Sabalenka won't fret over lackluster 2026 results
-
McIlroy returns to St. Jude to launch marathon PGA playoff push
-
Hometown hero Hudson-Smith basks in Euro glory
-
Guimaraes makes Arsenal debut in Como friendly
-
PSG down Aston Villa to retain UEFA Super Cup
-
Travis Kelce says wedding to Taylor Swift was 'best night of my life'
-
Trump's spokesperson Karoline Leavitt to step down
-
US stocks mostly up after data shows slightly lower inflation in July
-
'Imposing ignorance': US climate science under siege
-
Caracas protest denounces secrecy of Venezuela transition talks
-
As millions gazed in awe, a swathe of Spain plunged into darkness
-
Hudson-Smith regains Euro 400m title on home track
Trump ties autism risk to Tylenol as scientists urge caution
US President Donald Trump on Monday urged pregnant people not to take Tylenol over an unproven link to autism, and urged major changes to the standard vaccines given to babies.
The announcement comes as the White House has vowed to revolutionize health in the United States, as experts across medicine and science voice broad concern over the administration's initiatives.
Medical professionals have long cited acetaminophen as among the safest painkillers to take during pregnancy, especially as fever and pain can also pose dangers to both the mother and the developing fetus.
But Trump insisted that "taking Tylenol is not good."
"For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary. That's for instance, in cases of extremely high fever that you feel you can't tough it out," he said.
During his news conference Trump then pushed major changes to the routine vaccine schedule given to infants, insisting without evidence that there's "no reason" to vaccinate newborns against the incurable, highly contagious Hepatitis B.
Repeating anti-vaccine movement talking points, Trump said "I would say, wait until the baby is 12 years old and formed."
That statement stands in direct contradiction in the face of broad medical consensus formed over decades that the best way to prevent maternal transmission of the disease that can cause liver damage and cancer is to vaccinate newborns within the first day of life.
His statement comes days after an influential advisory panel handpicked by health chief Robert F. Kennedy Jr. stopped short of advising that a delay of one month of the first dose of Hepatitis B was warranted.
They deemed more discussion was necessary -- offering temporary relief to many experts in public health who said delaying that shot could have dire results.
- New therapy approved -
Identifying the cause of autism -- a complex condition connected to brain development that many experts believe occurs for predominantly genetic reasons -- has been a pet cause of Trump's controversial health chief Robert F. Kennedy Jr.
Earlier this year, Kennedy -- well-known for his anti-vaccine views and penchant for conspiracy theories -- vowed he would release findings regarding autism's cause by September 2025.
The administration's recent initiative to uncover autism's roots has been widely criticized. Kennedy has spent decades pushing discredited claims that link vaccines to autism.
He touted the drug leucovorin, a form of vitamin B first used to alleviate chemotherapy side effects, as an "exciting therapy" that could help children with autism.
The FDA on Monday said it was approving the drug's tablet form to help a subset of children who have "cerebral folate deficiency."
The Trump government's expected focus on acetaminophen, the active ingredient in Tylenol, is likely to meet broad critique.
The American College of Obstetricians and Gynecologists are among the major medical groups who have identified Tylenol as among the safest options for pain relief and fever reduction during pregnancy. Doctors already warn against its long-term use.
Another common over-the-counter pain reliever, ibuprofen, is generally considered unsafe for pregnant people, especially after the 20th week.
- 'Nuanced and uncertain' -
A literature review published last month concluded there was reason to believe a possible link between Tylenol exposure and autism existed -- but other studies have found an opposite result.
Researchers behind the August report cautioned that more study is needed and that pregnant people should not stop taking medication without consulting their doctors.
David Mandell, a psychiatric epidemiologist at the University of Pennsylvania, told AFP that research suggests the possible risks posed by taking Tylenol while pregnant seem "to be lower than the risk of having an uncontrolled infection during pregnancy."
The professor of psychiatry also emphasized that digging into the interaction of genetic and environmental factors is an area of critical research, but that to take on those studies with rigor demands decades of study and funding -- and cast the Trump administration's efforts as rushed.
The Coalition of Autism Scientists earlier called it "highly irresponsible and potentially dangerous to claim links between potential exposures and autism when the science is far more nuanced and uncertain."
"Secretary Kennedy's announcement will cause confusion and fear," said the group in a statement.
L.Adams--AT